Healio8 小时
Baseline factors impact odds for clinical remission with dupilumab in asthma
Researchers found increased odds for clinical remission on dupilumab with high blood eosinophil and fractional exhaled nitric ...
Positive results from the TEZSPIRE Phase III WAYPOINT trial highlight rapid and sustained ...
Full results from the positive Phase III WAYPOINT trial showed AstraZeneca and Amgen’s TEZSPIRE® (tezepelumab-ekko) significantly reduced nasal polyp severity, the need for subsequent surgery, and ...
Theravance Biopharma, Inc. Reports Record Fourth Quarter and Full Year 2024 Financial Results
US net sales, recognized by Viatris, reached an all-time high of $66.7 million in Q4 2024 and $238.6 million in FY 2024, up 10% and 8%, respectively ...